Takes 90 seconds 100% private free What is your goal weight
Reduced glutathione (GSH) yields several systemic effects, including improvements of liver abnormalities and diabetic complications, protection from viral infections, and antitumor activities [3]
54 In an RCT for DJBL in patients with type 2 diabetes mellitus and obesity, 24% of the patients in the DJBL group achieved a 15% reduction in body weight compared to 4% in the control group at 12 months
Our doctors craft tailored solutions for each patient
In November 2023, the FDA granted approval for Zepbound (tirzepatide) for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease